Clinical Trials Browser

Phase 2 × Karnofsky Performance Status × Clear all

NCT02663271 2022-06-23

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

Phase 2 Terminated

10 enrolled 13 charts

Glioblastoma, Glioma

NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms